Mayo Clinic Division of Nephrology and Hypertension, 200 First Street SW, Rochester, MN 55905, USA.
Clin J Am Soc Nephrol. 2011 Aug;6(8):1963-72. doi: 10.2215/CJN.02300311. Epub 2011 Jul 7.
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was developed using both CKD and non-CKD patients to potentially replace the Modification of Diet in Renal Disease (MDRD) equation that was derived with only CKD patients. The objective of our study was to compare the accuracy of the MDRD and CKD-EPI equations for estimating GFR in a large group of patients having GFR measurements for diverse clinical indications.
DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: A cross-sectional study was conducted of patients who underwent renal function assessment for clinical purposes by simultaneous measurements of serum creatinine and estimation of GFR using the MDRD and CKD-EPI equations and renal clearance of iothalamate (n = 5238).
Bias compared with measured GFR (mGFR) varied for each equation depending on clinical presentation. The CKD-EPI equation demonstrated less bias than the MDRD equation in potential kidney donors (-8% versus -18%) and postnephrectomy donors (-7% versus -15%). However, the CKD-EPI equation was slightly more biased than the MDRD equation in native CKD patients (6% versus 3%), kidney recipients (8% versus 1%), and other organ recipients (9% versus 3%). Among potential kidney donors, the CKD-EPI equation had higher specificity than the MDRD equation for detecting an mGFR <60 ml/min per 1.73 m(2) (98% versus 94%) but lower sensitivity (50% versus 70%).
Clinical presentation influences the estimation of GFR from serum creatinine, and neither the CKD-EPI nor MDRD equation account for this. Use of the CKD-EPI equation misclassifies fewer low-risk patients as having reduced mGFR, although it is also less sensitive for detecting mGFR below specific threshold values used to define CKD stages.
慢性肾脏病流行病学协作组(CKD-EPI)方程是使用慢性肾脏病(CKD)和非 CKD 患者开发的,旨在替代仅使用 CKD 患者推导的肾脏病饮食改良研究(MDRD)方程。我们的研究目的是比较 MDRD 和 CKD-EPI 方程在用于多种临床适应证的 GFR 测量的大量患者中估计 GFR 的准确性。
设计、设置、参与者和测量:对因临床目的而进行肾功能评估的患者进行了一项横断面研究,这些患者通过同时测量血清肌酐和使用 MDRD 和 CKD-EPI 方程估计 GFR 以及碘酞酸盐肾清除率(n = 5238)进行了评估。
与测量的肾小球滤过率(mGFR)相比,每个方程的偏差因临床表现而异。与 MDRD 方程相比,CKD-EPI 方程在潜在的肾供体中(-8%对-18%)和肾切除术后供体中(-7%对-15%)偏差较小。然而,在原发性 CKD 患者中(6%对 3%)、肾移植受者中(8%对 1%)和其他器官受者中(9%对 3%),CKD-EPI 方程的偏差略大。在潜在的肾供体中,CKD-EPI 方程检测 mGFR<60 ml/min/1.73 m2 的特异性高于 MDRD 方程(98%对 94%),但敏感性较低(50%对 70%)。
血清肌酐估计 GFR 受临床表现影响,而 CKD-EPI 和 MDRD 方程均未考虑到这一点。虽然 CKD-EPI 方程检测特定阈值以下的 mGFR 低于定义 CKD 阶段的阈值的敏感性较低,但它错误地将更少的低风险患者分类为 mGFR 降低。